文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

猪心脏骤停模型中使用亚甲蓝的效果:随机、盲法、安慰剂对照研究

The effects of methylene blue during and after cardiac arrest in a porcine model; a randomized, blinded, placebo-controlled study.
PubMed 文献 · Am J Emerg Med · 2023-08-25
一句话结论猪心脏骤停模型中,骤停期间及复苏后推注亚甲蓝未显著改善血流动力学,也未呈现既往输注给药所见的神经保护作用。

本研究在40头麻醉猪中建立急性心肌梗死并经历7分钟未处理心脏骤停的模型,随机分为生理盐水对照组、亚甲蓝2 mg/kg加生理盐水组(MB+盐水)和两次2 mg/kg亚甲蓝组(MB+MB),首次干预在第3次心律分析后给予,第二次剂量在达到自主循环恢复(ROSC)后1小时给予。主要结局为心脏骤停后乳酸水平变化。MB+MB组乳酸下降速度显著快于对照组(p=.007)和MB+盐水组(p=.02);初始ROSC比例、ROSC时间、累积去甲肾上腺素剂量组间无显著差异;MB+MB组复苏后脑甘油水平显著低于对照组(p=.03),但MRI显示表观弥散系数、脑血流量及动态对比增强MR灌注组间无差异。作者结论为推注亚甲蓝未显著改善血流动力学功能,也未产生既往输注给药所描述的神经保护效应。

要点

  • 在猪心脏骤停模型中,骤停期间及ROSC后1小时两次推注亚甲蓝2 mg/kg,使乳酸下降速度显著快于对照组(p=.007)和单次推注组(p=.02)。
  • 初始ROSC比例组间无显著差异:对照组11/13(85%)、MB+盐水组10/13(77%)、MB+MB组12/14(86%)(p=.81);ROSC时间组间亦无差异(p=.67)。
  • 累积去甲肾上腺素剂量组间无显著差异(p=.15),提示推注亚甲蓝未显著改善血流动力学功能。
  • MB+MB组复苏后脑甘油水平显著低于对照组(p=.03),但MRI的表观弥散系数、脑血流量及动态对比增强MR灌注组间无差异。
  • 作者结论:推注亚甲蓝未产生既往动物研究中输注亚甲蓝所描述的神经保护效应。

适用人群与场景

  • 麻醉猪急性心肌梗死模型,经历7分钟未处理心脏骤停。

处置流程与药物剂量

  • 首次干预于第3次心律分析后给予:对照组仅生理盐水,MB+盐水组给予2 mg/kg亚甲蓝加生理盐水,MB+MB组给予2 mg/kg亚甲蓝。
  • 第二次剂量于达到ROSC后1小时给予:MB+MB组再给予2 mg/kg亚甲蓝(MB+盐水组此时间点给生理盐水,对照组给生理盐水)。
  • 复苏后行重症监护与观察6小时,随后行脑MRI检查。

研究设计与关键结果

  • 研究类型:随机、盲法、安慰剂对照动物实验;40头麻醉猪。
  • 主要结局:心脏骤停后乳酸水平变化;所有组复苏后乳酸均升高,但MB+MB组乳酸下降速度显著快于对照组(p=.007)和MB+盐水组(p=.02)。
  • 初始ROSC比例:对照组11/13(85%)、MB+盐水组10/13(77%)、MB+MB组12/14(86%),组间无显著差异(p=.81);ROSC时间组间无差异(p=.67)。
  • 累积去甲肾上腺素剂量组间无显著差异(p=.15)。
  • MB+MB组复苏后脑甘油水平显著低于对照组(p=.03);MRI表观弥散系数、脑血流量及动态对比增强MR灌注组间无差异。

证据类型、等级与局限

  • 证据类型:随机、盲法、安慰剂对照动物实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:心脏骤停期间及复苏后推注亚甲蓝未显著改善血流动力学功能,也未产生既往输注亚甲蓝所描述的神经保护效应。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: To evaluate the effect of methylene blue administered as a bolus on return of spontaneous circulation (ROSC), lactate levels, vasopressor requirements, and markers of neurological injury in a clinically relevant pig model of cardiac arrest.

MATERIALS AND METHODS: 40 anesthetized pigs were subjected to acute myocardial infarction and 7 min of untreated cardiac arrest. Animals were randomized into three groups: one group received saline only (controls), one group received 2 mg/kg methylene blue and saline (MB + saline), and one group received two doses of 2 mg/kg methylene blue (MB + MB). The first intervention was given after the 3rd rhythm analysis, while the second dose was administered one hour after achieving ROSC. Animals underwent intensive care and observation for six hours, followed by cerebral magnetic resonance imaging (MRI). The primary outcome for this study was development in lactate levels after cardiac arrest. Categorical data were compared using Fisher's exact test and pointwise data were analyzed using one-way analysis of variance (ANOVA) or equivalent non-parametric test. Continuous data collected over time were analyzed using a linear mixed effects model. A value of p < .05 was considered statistically significant.

RESULTS: Lactate levels increased in all groups after cardiac arrest and resuscitation, however lactate levels in the MB + MB group decreased significantly faster compared with the control group (p = .007) and the MB + saline group (p = .02). The proportion of animals achieving initial ROSC was similar across groups: 11/13 (85%) in the control group, 10/13 (77%) in the MB + saline group, and 12/14 (86%) in the MB + MB group (p = .81). Time to ROSC did not differ between groups (p = .67). There was no significant difference in accumulated norepinephrine dose between groups (p = .15). Cerebral glycerol levels were significantly lower in the MB + MB group after resuscitation compared with control group (p = .03). However, MRI data revealed no difference in apparent diffusion coefficient, cerebral blood flow, or dynamic contrast enhanced MR perfusion between groups.

CONCLUSION: Treatment with a bolus of methylene blue during cardiac arrest and after resuscitation did not significantly improve hemodynamic function. A bolus of methylene blue did not yield the neuroprotective effects that have previously been described in animals receiving methylene blue as an infusion.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Johannsen CM, Nørholt C, Baltsen C, et al. The effects of methylene blue during and after cardiac arrest in a porcine model; a randomized, blinded, placebo-controlled study. Am J Emerg Med. 2023. PMID: 37659143. doi:10.1016/j.ajem.2023.08.041

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。